September 8, 2026
Bonus Content: UNH Is Earning More by Serving Fewer People. November Will Test It.
Cornelius Vanderbilt never manufactured a single thing that rode on his trains. He owned the track. Everyone else paid to use it.
That is the quiet lesson of every technology boom. The most durable fortunes are built by whoever owns the infrastructure other companies cannot function without.
In the AI era, that infrastructure is electricity. Global AI spending is projected at $2 trillion, and to support it the United States must more than triple its annual power capacity, from 25 gigawatts of data center demand in 2024 to more than 80 gigawatts by 2030.
American PowerGen is developing it: a 22 gigawatt pipeline of natural gas generation in Texas, where large new electricity users have already requested more than 430 gigawatts of new power. That’s nearly 5x the state’s current peak capacity.
Land secured across multiple ERCOT zones. Natural gas supply arranged. ERCOT interconnection studies completed. Air permits submitted. 3 gigawatts of that pipeline begins construction in 2027.
Nasdaq ticker “APGX” is reserved. Shares are $2.50 at a $27 million pre-money valuation, with up to 17% bonus shares for early investors.
Minimum investment: $1,000.
UNH Is Earning More by Serving Fewer People. November Will Test It.
Revenue growth is supposed to come from adding customers. UnitedHealth Group spent the first half of 2026 proving that the opposite can also be true.
Since the end of 2025, the company shed 965,000 Medicare Advantage members. Despite serving fewer seniors, it reported a sharp improvement in profitability, with its medical care ratio improving to 86.7% from 89.4% a year earlier, reflecting cost and pricing discipline, product design changes and stronger medical cost management. That is the core of UnitedHealth’s 2026 strategy in one data point: fewer members, better margins.
What the Numbers Actually Say
Consolidated revenues for the second quarter 2026 were $112.0 billion, with earnings from operations of $8.0 billion and a net margin of 4.9%. Revenue of $112.03 billion beat the roughly $110.8 billion analysts expected. Q1 told a similar story: revenues of $111.7 billion, with earnings from operations of $9.0 billion.
UnitedHealth has tied the membership pressure to pricing and benefit changes aimed at restoring margins, with exchange and Medicare Advantage enrollments both affected. Revenue has remained stable because higher pricing is offsetting the enrollment decline. That trade-off is deliberate. On its earnings calls, management has framed it as exiting unprofitable offerings and investing heavily in automation and AI, including about $1.5 billion of AI initiatives across the company.
The Strategic Interpretation
UnitedHealthcare expects 2026 Medicare Advantage enrollment to decline by approximately 1.1 million members, reflecting targeted exits from unprofitable plans. Medicare margins are now expected to finish the year above 3%. That margin recovery, not volume, is what the guidance raise reflects. The company now expects full-year 2026 adjusted net earnings of $19.50 to $20.00 per share, up from a prior outlook of more than $18.25 per share.
This is not a growth story. It is a pricing and mix story. The distinction matters heading into Q3, where the medical care ratio will either confirm the trend or snap back. Management has said it expects 2026 Medicare medical cost trends to come in below its initial estimate of around 10%. If that trend holds, the November 2 earnings date arrives with the MCR already as the consensus focus, not revenue.
Options Market Analysis
UNH options trade at a 30-day at-the-money implied volatility of about 29%, with IV rank around 19. The options market is still pricing a mid-single-digit to high-single-digit expected move into the nearest expirations, depending on the series used. Put/call positioning and the “most-active” contract mix shift day to day, so treat any single snapshot as a temperature check, not a thesis. The broader message is unchanged: options are not pricing a market that expects a violent reset.
Structured Trade Framework
Bull case: If Q3 MCR prints below 87% and full-year EPS guidance holds at $19.50 or above, the stock has room to compress its valuation discount further. A defined-risk structure would be a long call spread in October expiry, targeting recovery toward the $420-$430 range, with risk capped at the debit paid.
Bear case: A medical cost resurgence or deterioration in the ACA membership mix could reverse the MCR trend abruptly. For traders expecting a guidance cut, a long put spread below $360 captures asymmetric downside with limited premium at current IV levels.
Neutral case: Positive dealer gamma can mean hedging leans against price swings. A short strangle around the $360-$400 band collects premium in a low-to-mid IV environment while staying defined via wings.
Risk and Forward Outlook
UnitedHealthcare is forecasting a Medicare Advantage decline of about 1.1 million members for all of 2026, and it has also flagged exchange and Medicaid enrollment pressure tied to pricing, benefit design and eligibility changes. The question for November is whether pricing power sustains revenue while membership stabilizes, or whether next year’s enrollment cycle reopens the volume problem. The next expected earnings date is November 2, 2026.
Action Checklist
- Track Q3 medical care ratio against Q2’s 86.7% benchmark. Any move above 88% would challenge the full-year guidance.
- Watch October enrollment data for early 2027 Medicare Advantage signals.
- Low-to-mid IV rank can favor defined-risk premium-buying structures into event risk, while still keeping an eye on absolute implied volatility.
- Monitor the $19.50-$20.00 adjusted EPS corridor. A guidance cut would be the single largest near-term catalyst.
- Defined-risk structures are supported by current IV levels. Undefined short premium carries elevated gap risk into the earnings date.
